Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. chil. anat ; 17(2): 147-51, 1999. ilus
Artigo em Inglês | LILACS | ID: lil-269547

RESUMO

The vessel bundle formed by the ramification of the median sacral was studied in 20 armadillos (Dasypus novemcinctus). This bundle, considered to be rete mirabile, is located in the sacral region close to the spine and to the base of the tail. The parallel arrangement of its arteries and veing gives origin to a countercurrent system that probably prevents heat dissipation through the end of the tail, thus participating in the control of body temperature in the armadillo


Assuntos
Animais , Aorta Abdominal/anatomia & histologia , Tatus/anatomia & histologia , Artérias/anatomia & histologia
2.
Rev Soc Bras Med Trop ; 28(3): 233-6, 1995.
Artigo em Português | MEDLINE | ID: mdl-7480918

RESUMO

In this study the immunopotentiator levamisole as well as a mixture of BCG/Mycobacterium leprae were investigated in inactive lepromatous leprosy patients by using the Mitsuda reaction as a parameter. Twenty lepromatous patients ten years ago classified as histologically negative for Mitsuda's test were divided into three groups: five patients that were only retested with Mitsuda antigen; eight patients that received oral levamisol and seven patients that received a mixture of alive BCG plus autoclaved M. leprae. The results indicated that: 1) the levamisole did not alter the reactivity to lepromin in any of the patients studied; 2) neither the changes in the reactivity to lepromin by using the mixture (3 cases) nor those that occurred spontaneously (3 cases) were clear. They properly reflected the natural variation of patients with some degree of resistance to Mycobacterium leprae.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Vacina BCG/uso terapêutico , Imunoterapia , Hanseníase/imunologia , Levamisol/uso terapêutico , Mycobacterium leprae , Vacinas Bacterianas/uso terapêutico , Humanos , Hanseníase/terapia
3.
Hansenol Int ; 10(1-2): 23-31, 1985.
Artigo em Português | MEDLINE | ID: mdl-3880310

RESUMO

Hanseniasis patients and contacts of Virchowian patients, totaling 467 persons have been submitted to Mitsuda's reaction. These individuals have been divided into five groups: group 1 compounded of 59 persons, relatives of Virchowian patients; group 2 - 171 persons, employees of the Hospital Lauro de Souza Lima working there for more than one year; group 3 - 127 hanseniasis patients in activity, Mitsuda negative; group 4 - 63 hanseniasis patients in activity, Mitsuda positive; group 5 - 47 Virchowian patients, inactive, Mitsuda negative. The analysis of the data showed that: a) hanseniasis patients, both Mitsuda positive and negative, do not present positivity to Fernandez's reaction; b) early reaction can be observed more frequently in individuals of group 1 than in those of group 2. Mitsuda's antigen causes the reversal of Fernandez's reaction in about 30% of indirect contacts; c) the percentage of negative Mitsuda's reactions (without induration) does not differ between groups 1 and 2, though indurations smaller than 5 mm have been as many as 10 times more frequent in individuals of group 1. A second application of the antigen in Mitsuda negative persons showed the reversal of the test in 100% of the tested subjects.


Assuntos
Hipersensibilidade Tardia , Antígeno de Mitsuda/imunologia , Hanseníase/imunologia , Tuberculina/imunologia , Humanos , Imunidade Celular
4.
Med Cutan Ibero Lat Am ; 11(6): 423-30, 1983.
Artigo em Português | MEDLINE | ID: mdl-6366399

RESUMO

Approximately 55% of active lepromatous patients respond positively to the Rubino reaction. With arrested cases this rate of positivity lowers considerably to about 15%. In an effort to associate this reaction with the presence of bacilli, a study of 796 cases was undertaken. The patients were divided into: a control group, active tuberculoid cases, arrested tuberculoid cases, active borderline cases, arrested borderline cases, active lepromatous cases, and arrested lepromatous cases. The patients were submitted to the following tests: Rubino reaction, presence of cryoglobulins, and VDRL and PCR positivity. By the results obtained we may conclude that: a) A positive Rubino reaction may be present in all the forms of leprosy studied, this reaction having an inverse relationship with the organism's resistance to "M. leprae". b) The Rubino reaction has specificity to leprosy. c) This reaction does not depend on the number of bacilli present in the host. d) A positive Rubino reaction is not related to the presence of cryoglobulins in the serum, nor to VDRL or PCR positivity, nor to the length of time the patient's disease has been arrested. The authors present these findings and suggest that this reaction be used as one of the criteria for determining cure.


Assuntos
Testes de Aglutinação , Hanseníase/imunologia , Formação de Anticorpos , Proteína C-Reativa/análise , Crioglobulinas/análise , Humanos , Hanseníase/patologia , Lipoproteínas VLDL/sangue , Mycobacterium leprae/imunologia
5.
Med Cutan Ibero Lat Am ; 10(1): 9-14, 1982.
Artigo em Português | MEDLINE | ID: mdl-6750277

RESUMO

The Rubino reaction was studied in 178 leprosy patients to correlate its positivity, clinical form, E.N.L., and time and activity of the disease. The patients studied were classified according to the criteria established by the 1953 Madrid Congress. The results show that the tuberculoid patients presented negative Rubino reactions regardless of any of the parameters studied. The borderline patients showed 9% positive Rubino reaction not related to any of the observed parameters studied. The lepromatous patients showed a significant difference of positivity to the Rubino reaction when grouped as to the disease's active or non-active presence. Active lepromatous patients showed 55% of positivity to the Rubino reaction whereas patients considered clinically inactive showed only 6% of positivity. The fact that the Rubino reaction is negative in the majority of patients who are clinically cured would indicate that this test could be included as part of the criteria used in determining which clinically cured lepromatous patients can discontinue medication without risking a relapse.


Assuntos
Hanseníase/sangue , Adolescente , Adulto , Idoso , Eritema Nodoso/etiologia , Feminino , Testes de Hemaglutinação , Humanos , Hansenostáticos/administração & dosagem , Hanseníase/tratamento farmacológico , Hanseníase/patologia , Masculino , Pessoa de Meia-Idade , Recidiva
6.
Med Cutan Ibero Lat Am ; 10(4): 231-8, 1982.
Artigo em Português | MEDLINE | ID: mdl-6763656

RESUMO

Forty eight clinically arrested lepromatous patients were submitted to several tests to evaluate cellular immunological competence (PPD, Trichophytin, DNCB, determination of the percentage of T lymphocytes in the peripheral blood, and early and late reactions to the lepromin). The results of the Trychophytin test and of the lymphocyte percentage test did not differ from those of the control group, whereas the results to the PPD test were more often positive for the arrested Virchovian cases. All the patients presented positivity to the DNCB test, and none of them showed positivity to the Fernandez reaction. As for the late reaction to the lepromin, all the patients were negative, although in histopathological testing four degrees of reactivity was observed ranging from focal, non specific inflammatory reaction to granulomatous histiocytic with an epithelioid outline. By means of these results the authors were able to confirm that: 1. There is no cross reactivity between the PPD and lepromin tests. 2. Sulfone therapy does not interfere in immunocellular results for the tests employed. 3. Lepromatous patients respond like the general population to the unspecific sensitivity tests utilized. 4. The finding of histiocytic reaction with epithelioid outline in some biopsies of Mitsuda reaction in lepromatous patients, suggests the presence of a sub-population within this group, probably Borderline patients that suffered during the infection's evolution downgrading of theirs clinic and histological characteristics.


Assuntos
Hanseníase/imunologia , Dinitroclorobenzeno/imunologia , Histiócitos/imunologia , Humanos , Imunidade Celular , Antígeno de Mitsuda/imunologia , Hanseníase/patologia , Contagem de Leucócitos , Linfócitos T/imunologia , Tricofitina/imunologia , Tuberculina/imunologia
7.
Hansenol Int ; 5(1): 28-36, 1980 Jun.
Artigo em Português | MEDLINE | ID: mdl-7042562

RESUMO

The authors report their experiences in raising armadillos and the results obtained in inoculating them with M. leprae. They begin by reporting on the origin of the animals, how they were captured, and their efforts until they found the right kind of housing for the armadillos. They also tell of their attempts to develop the correct feeding procedures. The result is the feed used now in their laboratory: chicken feed mixed with bread, eggs, meat and milk. Along with this, they report on the way each animal is registered and the examination it undergoes upon admittance, namely, recording of its weight, rectal temperature, feces examination, hemogram and hemossedimentation. They also tell how animals are immobilized so as to take blood samples for the inoculations. Lastly, they present the results of the inoculations with M. leprae in three armadillos of the Euphractus sexticinctus species and 26 of the Dasypus novemcinctus species, with special reference to an armadillo of the D. novemcinctus species, which had systemic infection 15 months after being inoculated subcutaneously and intravenously. Bacilli were found in large quantities in various organs like the skin, lymph nodes, liver, kidneys and spleen. No bacilli were found in the myocardium, pancreas, thyroid and testicles. The authors are of the opinion that this is the first armadillo of the D. novemcinctus species to present experimental systemic infection with M. leprae in South America. Another armadillo, which has been inoculated with a suspension of 1.2 X 10(8) bacilli by the intracardiac route already showed nodules with bacilli on the abdominal wall 10 months after being inoculated. They believe that the results already obtained indicate that soon they will be able to provide material for institutions in Brazil as well as other countries that are interested in the study of M. leprae and in the preparation of the Mitsuda antigen which is so vital to the control of Hansen's disease.


Assuntos
Tatus/microbiologia , Hanseníase/microbiologia , Mycobacterium leprae/crescimento & desenvolvimento , Xenarthra/microbiologia , Ração Animal , Animais , Antígenos de Bactérias/imunologia , Modelos Animais de Doenças , Hanseníase/patologia , Linfonodos/patologia , Nervos Periféricos/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...